375 related articles for article (PubMed ID: 6215340)
1. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
Haubeck HD; Kölsch E
Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a T suppressor cell-inducing antigenic determinant shared by ADJ-PC-5 plasmacytoma and syngeneic BALB/c spleen cells.
Kloke O; Haubeck HD; Kölsch E
Eur J Immunol; 1986 Jun; 16(6):659-64. PubMed ID: 2424769
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of in vitro and in vivo functions of a tumor-specific T suppressor cell clone from a BALB/c mouse bearing the syngeneic ADJ-PC-5 plasmacytoma.
Haubeck HD; Kölsch E
J Immunol; 1985 Dec; 135(6):4297-302. PubMed ID: 2415609
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cellular anti-tumour responses by tumour-specific T suppressor lymphocytes.
Haubeck HD; Stutenkemper R; Kölsch E
Clin Exp Immunol; 1988 Oct; 74(1):47-52. PubMed ID: 2975538
[TBL] [Abstract][Full Text] [Related]
5. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
[TBL] [Abstract][Full Text] [Related]
6. Selective in-vitro activation of BALB/c T suppressor lymphocytes specific for syngeneic ADJ-PC-5 plasmacytoma cells.
Haubeck HD; Minkenberg I; Kölsch E
Clin Exp Immunol; 1988 Oct; 74(1):53-8. PubMed ID: 2975539
[TBL] [Abstract][Full Text] [Related]
7. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
[TBL] [Abstract][Full Text] [Related]
8. Differences in the induction of tumorspecific T suppressor lymphocytes among the peritoneal exudate cells in histocompatible BALB/cAnPt and BALB/cJ mouse sublines.
Lügering N; Kölsch E
Immunobiology; 1991 Dec; 184(1):106-10. PubMed ID: 1839294
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumour-specific cytotoxic T-cell responses against the syngeneic BALB/c plasmacytoma ADJ-PC-5 by tumour-induced CD8+ regulatory T cells via IFN-gamma.
Pauels HG; Specht C; Becker C; Kölsch E
Scand J Immunol; 1996 Apr; 43(4):421-30. PubMed ID: 8668922
[TBL] [Abstract][Full Text] [Related]
10. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. IV. Tumor-specific T suppressor cells, induced at early stages of tumorigenesis, act on the induction phase of the tumor-specific cytotoxic T cell response.
Haubeck HD; Kölsch E
Immunobiology; 1986 Jul; 171(4-5):357-65. PubMed ID: 2943667
[TBL] [Abstract][Full Text] [Related]
11. Splenic immune effector and suppressor cells in mice bearing a growing plasmacytoma.
Chen YH; Anderson AB; Williams KG
Cancer Res; 1985 Nov; 45(11 Pt 1):5473-9. PubMed ID: 2932218
[TBL] [Abstract][Full Text] [Related]
12. Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.
Nio Y; Ohgaki K; Tobe T
J Clin Lab Immunol; 1989 May; 29(1):37-43. PubMed ID: 2534133
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression in plasmacytoma: induction of suppressor cells.
Chen Y; Hwang LT; Heller P
Clin Exp Immunol; 1982 Jan; 47(1):191-6. PubMed ID: 6212173
[TBL] [Abstract][Full Text] [Related]
14. Effector mechanism of tumor immunity in murine plasmacytoma.
Chen YH; Anderson AB
Cancer Res; 1988 Mar; 48(6):1398-403. PubMed ID: 3257896
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
Bear HD
Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
[TBL] [Abstract][Full Text] [Related]
16. CD8+ tumor-specific Tc cells primed in vivo or in vitro against the BALB/c plasmacytoma ADJ-PC-5 use the same TcR V beta families but display distinct TC1 or TC2 characteristics.
Becker C; Kölsch E; Pauels HG
Immunobiology; 1997 Jun; 197(1):16-30. PubMed ID: 9241528
[TBL] [Abstract][Full Text] [Related]
17. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
Marsili MA; Walker MC; Phillips-Quagliata JM
Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
[TBL] [Abstract][Full Text] [Related]
18. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
Good MF; Nossal GJ
J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
[TBL] [Abstract][Full Text] [Related]
19. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
Flood PM; Philipps C; Taupier MA; Schreiber H
J Immunol; 1980 Jan; 124(1):424-30. PubMed ID: 6965296
[TBL] [Abstract][Full Text] [Related]
20. Differential activation of CD8+ tumor-specific Tc1 and Tc2 cells by an IL-10-producing murine plasmacytoma.
Specht C; Pauels HG; Becker C; Kölsch E
Dev Immunol; 1998; 6(3-4):331-42. PubMed ID: 9814607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
